Literature DB >> 19329885

Hela l-CaD is implicated in the migration of endothelial cells/endothelial progenitor cells in human neoplasms.

Ping-Pin Zheng1, Marcel van der Weiden, Johan M Kros.   

Abstract

Caldesmon (CaD) is a major actin-binding protein distributed in a variety of cell types. No functional differences among the isoforms in in vitro studies were found so far. In a previous study we found that the low molecular caldesmon isoform (Hela l-CaD) is expressed in endothelial cells (ECs)/endothelial progenitor cells (EPCs) in tumor vasculature of various human tumors. Activation of cell motility is necessary for the navigation of the tip ECs during angiogenesis, and migration of EPCs from the bone marrow during vasculogenesis. In the present study we searched for features of motility and the intracellular expression sites of Hela l-CaD in ECs/EPCs of various human tumors under histologically preserved microenviroment. We discovered a variety of motility-related cell protrusions like filopodia, microspikes, lamellipodia, podosomes, membrane blebs and membrane ruffles in the activated ECs/EPCs. Hela l-CaD appeared to be invariably expressed in the subregions of these cell protrusions. The findings suggest that Hela l-CaD is implicated in the migration of ECs/EPC in human neoplasms where they contribute to tumor vasculogenesis and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19329885      PMCID: PMC2633982          DOI: 10.4161/cam.1.2.4332

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  58 in total

1.  Membrane ruffles in cell migration: indicators of inefficient lamellipodia adhesion and compartments of actin filament reorganization.

Authors:  Bodo Borm; Robert P Requardt; Volker Herzog; Gregor Kirfel
Journal:  Exp Cell Res       Date:  2005-01-01       Impact factor: 3.905

Review 2.  Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance.

Authors:  Mihail Hristov; Christian Weber
Journal:  J Cell Mol Med       Date:  2004 Oct-Dec       Impact factor: 5.310

Review 3.  Mechanotransduction in endothelial cell migration.

Authors:  Song Li; Ngan F Huang; Steven Hsu
Journal:  J Cell Biochem       Date:  2005-12-15       Impact factor: 4.429

Review 4.  Podosomes at a glance.

Authors:  Stefan Linder; Petra Kopp
Journal:  J Cell Sci       Date:  2005-05-15       Impact factor: 5.285

5.  Dynamic modes of the cortical actomyosin gel during cell locomotion and division.

Authors:  Ewa Paluch; Cécile Sykes; Jacques Prost; Michel Bornens
Journal:  Trends Cell Biol       Date:  2005-12-01       Impact factor: 20.808

6.  Low-molecular weight caldesmon as a potential serum marker for glioma.

Authors:  Ping-Pin Zheng; Wim C Hop; Peter A E Sillevis Smitt; Martin J van den Bent; Cees J J Avezaat; Theodorus M Luider; Johan M Kros
Journal:  Clin Cancer Res       Date:  2005-06-15       Impact factor: 12.531

7.  Differential expression of Hela-type caldesmon in tumour neovascularization: a new marker of angiogenic endothelial cells.

Authors:  Ping-Pin Zheng; M van der Weiden; Johan M Kros
Journal:  J Pathol       Date:  2005-02       Impact factor: 7.996

8.  Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells.

Authors:  K Herbrig; S Haensel; U Oelschlaegel; F Pistrosch; S Foerster; J Passauer
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

9.  Mammal-specific, ERK-dependent, caldesmon phosphorylation in smooth muscle. Quantitation using novel anti-phosphopeptide antibodies.

Authors:  G D'Angelo; P Graceffa; C A Wang; J Wrangle; L P Adam
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

Review 10.  AC133/CD133/Prominin-1.

Authors:  Sergey V Shmelkov; Ryan St Clair; David Lyden; Shahin Rafii
Journal:  Int J Biochem Cell Biol       Date:  2005-04       Impact factor: 5.085

View more
  7 in total

Review 1.  Circulating glioma biomarkers.

Authors:  Johan M Kros; Dana M Mustafa; Lennard J M Dekker; Peter A E Sillevis Smitt; Theo M Luider; Ping-Pin Zheng
Journal:  Neuro Oncol       Date:  2014-09-24       Impact factor: 12.300

Review 2.  Diversification of caldesmon-linked actin cytoskeleton in cell motility.

Authors:  Taira Mayanagi; Kenji Sobue
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

3.  cGMP-dependent protein kinase Iβ regulates breast cancer cell migration and invasion via interaction with the actin/myosin-associated protein caldesmon.

Authors:  Raphaela Schwappacher; Hema Rangaswami; Jacqueline Su-Yuo; Aaron Hassad; Ryan Spitler; Darren E Casteel
Journal:  J Cell Sci       Date:  2013-02-15       Impact factor: 5.285

4.  Histochemical localization of caldesmon isoforms in colon adenocarcinoma and lymph node metastases.

Authors:  Christoph Köhler
Journal:  Virchows Arch       Date:  2011-05-29       Impact factor: 4.064

5.  Isocitrate dehydrogenase 1R132H mutation in microglia/macrophages in gliomas: indication of a significant role of microglia/macrophages in glial tumorigenesis.

Authors:  Ping-Pin Zheng; Marcel van der Weiden; Peter J van der Spek; Arnaud J P E Vincent; Johan M Kros
Journal:  Cancer Biol Ther       Date:  2012-08-01       Impact factor: 4.742

6.  Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.

Authors:  Myung-Shin Lee; Jisu Lee; Joo Heon Kim; Won Tae Kim; Wun-Jae Kim; Hanjong Ahn; Jinsung Park
Journal:  Oncotarget       Date:  2015-11-24

Review 7.  Emerging role of caldesmon in cancer: A potential biomarker for colorectal cancer and other cancers.

Authors:  Alya R Alnuaimi; Vidhya A Nair; Lara J Bou Malhab; Eman Abu-Gharbieh; Anu Vinod Ranade; Gianfranco Pintus; Mohamad Hamad; Hauke Busch; Jutta Kirfel; Rifat Hamoudi; Wael M Abdel-Rahman
Journal:  World J Gastrointest Oncol       Date:  2022-09-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.